Cargando…

Prognostic Roles of N6-Methyladenosine METTL3 in Different Cancers: A System Review and Meta-Analysis

BACKGROUND: Recent studies have shown that methyltransferase-like 3, a catalytic enzyme that is predominant in the N6-methyladenosine methyltransferase system, is abnormally expressed in various types of carcinoma and is correlated with poorer prognosis. However, the clinical functions of methyltran...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, KuangZheng, Gao, Yue, Gan, Kai, Wu, YuQing, Xu, Bin, Zhang, LiHua, Chen, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482712/ https://www.ncbi.nlm.nih.gov/pubmed/33631954 http://dx.doi.org/10.1177/1073274821997455

Ejemplares similares

Solution structure of the RNA recognition domain of METTL3-METTL14 N(6)-methyladenosine methyltransferase
por: Huang, Jinbo, et al.
Publicado: (2018)

METTL3-mediated mRNA N(6)-methyladenosine is required for oocyte and follicle development in mice
por: Mu, Haiyuan, et al.
Publicado: (2021)

N (6)-methyladenosine modification and METTL3 modulate enterovirus 71 replication
por: Hao, Haojie, et al.
Publicado: (2019)

The RNA N6-Methyladenosine Methyltransferase METTL3 Promotes the Progression of Kidney Cancer via N6-Methyladenosine-Dependent Translational Enhancement of ABCD1
por: Shi, Yue, et al.
Publicado: (2021)

Multifaceted Roles of the N(6)-Methyladenosine RNA Methyltransferase METTL3 in Cancer and Immune Microenvironment
por: Hu, Chenxi, et al.
Publicado: (2022)

METTL14 is a chromatin regulator independent of its RNA N(6)-methyladenosine methyltransferase activity
por: Dou, Xiaoyang, et al.
Publicado: (2023)

Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis
por: Zhou, Yaqing, et al.
Publicado: (2022)

The Clinical Significance and Prognostic Value of HER2 Expression in Bladder Cancer: A Meta-Analysis and a Bioinformatic Analysis
por: Gan, Kai, et al.
Publicado: (2021)

The N(6)-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy
por: Dorn, Lisa E., et al.
Publicado: (2019)

The N(6)-methyladenosine methyltransferase METTL16 enables erythropoiesis through safeguarding genome integrity
por: Yoshinaga, Masanori, et al.
Publicado: (2022)

METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer
por: Yue, Ben, et al.
Publicado: (2019)

N6-Methyladenosine Methyltransferase METTL14-Mediated Autophagy in Malignant Development of Oral Squamous Cell Carcinoma
por: Wang, Fang, et al.
Publicado: (2021)

N(6)-Methyladenosine METTL3 Modulates the Proliferation and Apoptosis of Lens Epithelial Cells in Diabetic Cataract
por: Yang, Jun, et al.
Publicado: (2020)

N-6-Methyladenosine in Vasoactive microRNAs during Hypoxia; A Novel Role for METTL4
por: van den Homberg, Daphne A. L., et al.
Publicado: (2022)

METTL3-Dependent N6-Methyladenosine Modification Programs Human Neural Progenitor Cell Proliferation
por: Zhao, Yuan, et al.
Publicado: (2023)

SP1 Expression and the Clinicopathological Features of Tumors: A Meta-Analysis and Bioinformatics Analysis
por: Gao, Yue, et al.
Publicado: (2021)

The Role of METTL3-Mediated N6-Methyladenosine (m6A) of JPH2 mRNA in Cyclophosphamide-Induced Cardiotoxicity
por: Zhu, Min, et al.
Publicado: (2021)

METTL3-mediated N(6)-methyladenosine mRNA modification enhances long-term memory consolidation
por: Zhang, Zeyu, et al.
Publicado: (2018)

METTL3-Mediated N6-Methyladenosine Modification Is Involved in the Dysregulation of NRIP1 Expression in Down Syndrome
por: Shi, Weili, et al.
Publicado: (2021)

Acute depletion of METTL3 implicates N(6)-methyladenosine in alternative intron/exon inclusion in the nascent transcriptome
por: Wei, Guifeng, et al.
Publicado: (2021)

N6-Methyladenosine Modification of CIRCKRT17 Initiated by METTL3 Promotes Osimertinib Resistance of Lung Adenocarcinoma by EIF4A3 to Enhance YAP1 Stability
por: Ji, Ying, et al.
Publicado: (2022)

The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal and leukemia cells
por: Vu, Ly P., et al.
Publicado: (2017)

N(6)-methyladenosine (m(6)A) writer METTL3 accelerates the apoptosis of vascular endothelial cells in high glucose
por: Li, Zhenjin, et al.
Publicado: (2023)

N(6)-Methyladenosine Methyltransferase METTL3 Alleviates Diabetes-Induced Testicular Damage through Modulating TUG1/Clusterin Axis
por: Tian, Yuan, et al.
Publicado: (2023)

Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N(6)-methyladenosine of Notch1
por: Gu, Chaohui, et al.
Publicado: (2019)

METTL14 aggravates podocyte injury and glomerulopathy progression through N(6)-methyladenosine-dependent downregulating of Sirt1
por: Lu, Zhihui, et al.
Publicado: (2021)

N(6)-methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1/HK2 modification
por: Wang, Qianqing, et al.
Publicado: (2020)

METTL3 Induces AAA Development and Progression by Modulating N6-Methyladenosine-Dependent Primary miR34a Processing
por: Zhong, Lintao, et al.
Publicado: (2020)

The METTL5-TRMT112 N(6)-methyladenosine methyltransferase complex regulates mRNA translation via 18S rRNA methylation
por: Sepich-Poore, Caraline, et al.
Publicado: (2022)

Analysis approaches for the identification and prediction of N(6)-methyladenosine sites
por: Yang, Yuwei, et al.
Publicado: (2022)

METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer
por: Chen, Xiaoxiang, et al.
Publicado: (2020)

METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing
por: Chen, Xiaoxiang, et al.
Publicado: (2020)

N6-methyladenosine methyltransferase METTL3 affects the phenotype of cerebral arteriovenous malformation via modulating Notch signaling pathway
por: Wang, Lin-jian, et al.
Publicado: (2020)

Arginine methylation of METTL14 promotes RNA N(6)-methyladenosine modification and endoderm differentiation of mouse embryonic stem cells
por: Liu, Xiaona, et al.
Publicado: (2021)

METTL3 suppresses neuropathic pain via modulating N6-methyladenosine-dependent primary miR-150 processing
por: Zhang, Le, et al.
Publicado: (2022)

METTL3-mediated N(6)-methyladenosine modification governs pericyte dysfunction during diabetes-induced retinal vascular complication
por: Suo, Long, et al.
Publicado: (2022)

METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma
por: Zhang, Zhijin, et al.
Publicado: (2023)

Suppression of Wnt/β-catenin Signaling in PDAC via METTL16-mediated N6-methyladenosine Modification of DVL2
por: Yu, Lanting, et al.
Publicado: (2023)

Correction: Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N6 - methyladenosine of Notch1
por: Gu, Chaohui, et al.
Publicado: (2023)

METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N(6)-methyladenosine-dependent YTHDF binding
por: Wang, Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_841ibcouvu1ep9faeplv2gj6ob